Today, FINOX Biotech (Finox AG) announced the 8 winners of its 2016 FORWARD (Finox Offers Research Work Award in Reproductive Development) competition – a highly-competitive, fertility research grant that is dedicated to fostering innovation in reproductive medical research, worldwide.
The FORWARD Scientific Committee, formed by an internal Finox committee with expertise in assisted reproductive technology, reproductive endocrinology, embryology, clinical science, clinical study management and regulatory affairs, reviewed 46 applications from 14 countries across Europe applying rigorous scientific criteria. There was a very high academic standard of applications, which covered an exciting range of topics – from gamete viability and endometrial receptivity to personalized treatment.
The winning Grants were awarded to Prof. Roy Homburg (United Kingdom), Dr. Paola Scaruffi (Italy), Dr. Ernesto Bosch (Spain), Prof. Udo R. Markert (Germany), Dr. Inge Errebo Agerholm (Denmark), Dr. Romain Imbert (Belgium), Prof. Charles Chapron and Dr. Pietro Santulli (France) and Dr. Thomas Freour (France) based on their proposals’ feasibility, innovation, value to the field and aligned to FINOX’s commitment in bringing science to practice and improving fertility treatments for patients seeking to become parents.
Gavin Jelic-Masterton, CEO of FINOX Biotech commented, “The FORWARD initiative demonstrates FINOX Biotech’s continued commitment to fostering innovative, fertility-therapy research across the globe. Within the next 5 years, these international teams of scientists will be awarded a total of EUR 1 million to conduct their innovative research. Their promising, cutting-edge work can lead to lasting benefits for patients seeking to become parents. We look forward to funding these visionary projects and supporting their success.”
For further information about the FORWARD winners and their work, please visit www.finoxbiotech.com/FORWARD.
The next FORWARD GRANT will be opened for new applications at the ESHRE meeting Geneva 2017.
About FINOX Biotech
FINOX Biotech (FINOX AG) is a biopharmaceutical company with its corporate headquarters in Burgdorf, Switzerland. FINOX Biotech was founded in 2007 with a vision to become a leading company in the field of fertility therapies, by combining high-quality Swiss medicines with innovative, award-winning delivery devices.
For further information please visit www.finoxbiotech.com or contact us at: email@example.com / +41 34 426 11 11. FINOX Biotech / Technikumstrasse 2 / 3401 Burgdorf / Switzerlandback to news